Glotelmitan Tablets 40 mg (Telmisartan)

Adult dose

In the treatment of primary hypertension, the recommended oral dose is 40 mg of Telmisartan once daily, which may be effective at 20 mg once daily depending on the patient. If necessary, it may be increased to 80 mg once daily. For the reduction of cardiovascular disease risk, 80 mg oral administration once daily is recommended. For patients with liver impairment (mild to moderate), the dose should not exceed 40 mg once daily.

This medication can cause serious harm to the fetus and newborn if taken during pregnancy, so it should be stopped immediately if pregnancy is confirmed. Individuals allergic to this medication or its components, pregnant or breastfeeding women, those with severe liver impairment, certain hereditary angioedema patients, and individuals with diabetes or severe kidney impairment should not use this medication. Elderly patients, those with hyperkalemia, liver impairment, valvular heart disease, and ischemic heart disease should use this medication with caution. While taking this medication, there may be adverse reactions such as blood pressure reduction, dizziness, headaches, dyspepsia, muscle pain, vascular edema, and renal failure, so symptoms should be closely monitored. It is essential to periodically check blood potassium levels and kidney function, and consult a healthcare professional immediately if hyperkalemia or worsening kidney function is suspected. Caution is needed when this medication is taken with other antihypertensive agents, as blood pressure may drop too low, and interactions may occur with specific medications, so it is essential to inform of any medications being taken. It is advisable to discontinue this medication 24 hours before surgery, and caution should be exercised while driving or operating dangerous machinery due to possible dizziness or drowsiness. This medication is not recommended for children as safety and efficacy have not been established, and overdose may result in symptoms such as hypotension, dizziness, and renal failure requiring immediate treatment. This medication should be stored out of reach of children, and it is advisable for pregnant or breastfeeding women not to use it.

Serious side effects

• Sepsis
• anaphylactic reaction
• angioedema
• toxic skin rash
• eczema
• urticaria
• angioedema (potentially fatal outcome)
• renal failure
• shock
• loss of consciousness

Mild side effects

• Upper respiratory infection
• urinary tract infection
• anemia
• thrombocytopenia
• eosinophilia
• hypersensitivity
• hyperkalemia
• hypoglycemia
• depression
• insomnia

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is important to maintain the storage temperature between 1°C and 30°C.

Appearance

White rectangular tablets

Package unit

30 tablets/bottle